United States· US:83781-007_0e031aa5-edf5-8c9d-e063-6394a90afee3
Sumifun Knee Relieve Patch
A medicinal product containing camphor (synthetic); borneol; menthol, registered in United States by Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CAMPHOR (SYNTHETIC); BORNEOL; MENTHOL
- Manufacturer
- Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1183781-007-01
- ndc11837810070124 PATCH in 1 BOX (83781-007-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2d58e3f-857f-4330-8150-2571ee246f7e GET /v1/drugs/f2d58e3f-857f-4330-8150-2571ee246f7e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1.5; 1.2; 1",
"substance": "CAMPHOR (SYNTHETIC); BORNEOL; MENTHOL",
"productndc": "83781-007",
"dosage_form": "PATCH",
"dea_schedule": null,
"strength_unit": "g/1001; g/1001; g/1001",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about camphor (synthetic); borneol; menthol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.